Indaptus Therapeutics shareholders approve reverse stock split authorization at annual meeting

Indaptus Therapeutics, Inc.

Elected Class I directors: Gilbert, Karah, Martell; each received ~3.4M votes for.
Ratified Haskell & White LLP as independent auditor for FY2025 (7,416,332 for).
Advisory say-on-pay approved: 3,346,942 for, 768,207 against.
Reverse stock split amendment approved (6,777,054 for); ratio 1:5 to 1:28, board discretion.
Approximately 52% of outstanding shares (8,386,348) were represented at the meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.